Associate Director of National Intelligence and Chief Information Officer

Simplilearn Strengthens Its Teams in the US and India Through Key Leadership Appointments

Retrieved on: 
Tuesday, July 18, 2023
Cloud, Grand Valley State University, Learning, Associate Director of National Intelligence and Chief Information Officer, Product marketing, Software as a service, Adviser, University, Partnership, Skillsoft, 2U, University of Notre Dame, Program management, Associate, Organization, Student, Internet, CRM, Knowledge, Growth, IIT Kanpur, Content, LATAM, Management, Tutoring, Tourism, Priyam, Educational technology, Marketing, Supply

These strategic appointments mark a pivotal moment in Simplilearn's ongoing growth strategy, highlighting the company's unwavering commitment to expanding and reinforcing its teams within India and across international markets.

Key Points: 
  • These strategic appointments mark a pivotal moment in Simplilearn's ongoing growth strategy, highlighting the company's unwavering commitment to expanding and reinforcing its teams within India and across international markets.
  • Mr. Priyam Sachan has joined Simplilearn as Vice President, Marketing for India.
  • Mr. Kevin Adams has joined Simplilearn as Vice President, Commercial Sales, in the US.
  • Mr. Priyam Sachan, Vice President, Marketing, India, said, "I am honored and elated to become a part of the Simplilearn family as the VP of Marketing.

TRUE Cresset Names Brandon Williams and Jon Marc Carrier as Wealth Advisors

Retrieved on: 
Tuesday, July 18, 2023
Bachelor of Science in Information Technology, NFL, Associate Director of National Intelligence and Chief Information Officer, Partnership, International, Super Bowl, NFL International Series, 1983 NFL Draft, Tennessee State University, Dartmouth College, Government, Athlete, Player, LSU Football Operations Center, National Football League Draft, Carrier, History of the Los Angeles Rams, Cresset, Sport

CHICAGO, July 18, 2023 /PRNewswire/ -- TRUE Cresset | Sports + Entertainment announced today that it has hired Brandon Williams as Director, Wealth Advisor; and Jon Marc Carrier as Associate Director, Wealth Advisor. With extensive experience in professional sports business and operations, Williams and Carrier will work closely with TRUE Cresset's professional athlete clients to identify and create opportunities to build and grow their financial portfolios for the long term.

Key Points: 
  • CHICAGO, July 18, 2023 /PRNewswire/ -- TRUE Cresset | Sports + Entertainment announced today that it has hired Brandon Williams as Director, Wealth Advisor; and Jon Marc Carrier as Associate Director, Wealth Advisor.
  • "Brandon and Jon's extensive experience working with professional athletes and hyper client-focused mindset make them a perfect fit for TRUE Cresset.
  • We are incredibly excited to welcome them to the team," said Doug Raetz , Co-President of TRUE Cresset Sports + Entertainment.
  • I am excited about bringing those passions together at TRUE Cresset," Carrier said.

Optimizing Medical Information Technology to Improve the Customer Experience, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, July 17, 2023
Medical Communications for Combat Casualty Care, Associate Director of National Intelligence and Chief Information Officer, PPD, Operation, Noise, Thermo Fisher Scientific, Customer experience, Medical device

TORONTO, July 17th, 2023 /PRNewswire-PRWeb/ -- In the rapidly changing landscape of medical information technology, it's more vital than ever for medical affairs leaders to keep pace with innovative tools and strategies. To aid in this endeavor, a groundbreaking webinar has been announced, aimed at discussing practical applications of current medical information technology and its benefits for companies and their customers.

Key Points: 
  • TORONTO, July 17th, 2023 /PRNewswire-PRWeb/ -- In the rapidly changing landscape of medical information technology, it's more vital than ever for medical affairs leaders to keep pace with innovative tools and strategies.
  • To aid in this endeavor, a groundbreaking webinar has been announced, aimed at discussing practical applications of current medical information technology and its benefits for companies and their customers.
  • The webinar, titled "Optimizing Medical Information Technology to Improve the Customer Experience," will delve into the unique regulatory and compliance challenges in the medical information industry.
  • The webinar will provide guidance on cutting through the noise of new medical information technology offerings.

Athira Pharma Presents Phase 2 Clinical Data Correlating Improvements in Biomarkers of Neurodegeneration and Neuroinflammation with Improvements in Measures of Cognition and Function in Alzheimer’s Disease

Retrieved on: 
Monday, July 17, 2023
ACT, Athira Pharma, Cognition, Associate Director of National Intelligence and Chief Information Officer, Neuron, Drug development, GFAP, Glial fibrillary acidic protein, Doctor of Philosophy, Phosphorylation, Macrophage, AFL, Deficit spending, Mini–Mental State Examination, Toxicity, LPS, Biomarker, Inflammation, Pathology, Bangladesh Technical Education Board, Plasma, St. Kevin's Church, Camden Row, Dublin, AAIC, Oxidative stress, Patient, Amyloid, Poster, Pharmacology, ALS, FTD, Conference, Alzheimer's disease, Neuroinflammation, Pharmaceutical industry, Medical imaging, Vaccine, Aroma compound, MMSE

BOTHELL, Wash., July 17, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, is presenting new data supporting its pipeline of small molecule therapeutic candidates designed to enhance the HGF/MET neurotrophic system. The data are being presented in three poster presentations at the Alzheimer’s Association International Conference (AAIC) 2023, taking place July 16 – 20, 2023, virtually and in Amsterdam, Netherlands.

Key Points: 
  • “These findings underscore the potential clinical utility of biomarkers of neurodegeneration and neuroinflammation in Alzheimer's disease, and help elucidate the neuroprotective mechanisms of this promising product candidate,” said Hans J. Moebius, M.D., Ph.D., Chief Medical Officer of Athira Pharma.
  • This was a post-hoc analysis of the randomized, placebo-controlled Phase 2 ACT-AD study and data from the open-label extension study in patients with mild-to-moderate Alzheimer’s disease.
  • NfL and GFAP improvements significantly correlate with a composite score of cognition and function, further supporting the clinical utility of these biomarkers.
  • The information presented in this press release is solely the responsibility of Athira Pharma and does not necessarily represent the official views of the National Institutes of Health.

Prairie Provident Resources Announces Appointment of Glenn Hamilton and Kathy Turgeon to the Board of Directors

Retrieved on: 
Friday, July 14, 2023
Exercise, Associate Director of National Intelligence and Chief Information Officer, Interim, Institute of Corporate Directors, University, PPR, Senior, Controller, Internal audit, Accounting, Melville Island oil sands, Organization, Institute of Chartered Accountants of India, Russell v Northern Bank Development Corp Ltd, CFO, TSX, Inter Pipeline, Commerce, Management, Security (finance), Peyto

CALGARY, Alberta, July 14, 2023 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. (TSX:PPR) (“Prairie Provident” or the “Company”) is pleased to announce the appointment of Mr. Glenn Hamilton and Ms. Kathy Turgeon to its Board of Directors (the “Board”).

Key Points: 
  • CALGARY, Alberta, July 14, 2023 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. (TSX:PPR) (“Prairie Provident” or the “Company”) is pleased to announce the appointment of Mr. Glenn Hamilton and Ms. Kathy Turgeon to its Board of Directors (the “Board”).
  • Mr. Hamilton and Ms. Turgeon have been appointed to the Board pursuant to the exercise of that right.
  • Mr. Hamilton and Ms. Turgeon, together with continuing directors Patrick McDonald, Ajay Sabherwal and Matthew Shyba, will be nominated for reelection at the meeting.
  • The recruitment and appointment of a permanent CFO will similarly be overseen and concluded by the reconstituted Board.

PODD Drug Delivery Conference Announces 2023 Keynotes and Agenda

Retrieved on: 
Wednesday, July 12, 2023
Teva Pharmaceuticals, Computational biology, GSK, Amgen, Gilead Sciences, Associate Director of National Intelligence and Chief Information Officer, Senior, Takeda, Administration, Chiesi Farmaceutici, Roche, Gene editing, Copley Place, Bristol Myers Squibb, Medicine, Research, MIT, Strategic Innovation Fund, Brain, CNS, AstraZeneca, PNS, AAV, Beam Therapeutics, Rare, Digital technology, Eli Lilly and Company, Novartis, Patient, AbbVie, Device, Novo Nordisk, Sanofi, Ionis Pharmaceuticals, Johnson & Johnson, Therapy, Conference, Takeda Pharmaceutical Company, Pharmaceutical industry, Medical device, Genentech, Pfizer

NEW YORK, July 12, 2023 /PRNewswire-PRWeb/ -- The Conference Forum announced the 13th annual PODD: Partnership Opportunities in Drug Delivery conference will take place October 16-17 at the Westin Copley Place, in Boston, MA.

Key Points: 
  • The Conference Forum announced the 13th annual PODD Drug Delivery Conference's 2023 keynotes and plenary sessions.
  • NEW YORK, July 12, 2023 /PRNewswire-PRWeb/ -- The Conference Forum announced the 13th annual PODD: Partnership Opportunities in Drug Delivery conference will take place October 16-17 at the Westin Copley Place, in Boston, MA.
  • "PODD is the most comprehensive industrial drug delivery partnering conference annually held in Boston," said Vincent Ling, Senior Director, Center for External Innovation at Takeda.
  • The PODD 2023 keynotes and featured speakers include:
    MIT's Dr Robert Langer, a pioneer in the research and development of drug delivery technology, will discuss the state of innovation in the drug delivery industry.

Q2B23 Tokyo Conference Returns to Foster Quantum Computing Community in Asia

Retrieved on: 
Monday, July 10, 2023
Diamond, State of Play (conference series), Hitachi, HSBC, Associate Director of National Intelligence and Chief Information Officer, Software, PALO, Jijiga Airport, Keio University, Government, BCG, QC Ware, Q2B, Commercial Affairs Department, Toshiba, Quantum, Fujitsu, Growth, Knowledge, Keysight, AWS, NEC, IonQ, Bridgestone, Quantum machine learning, Microscope, Video game

PALO ALTO, Calif., July 10, 2023 /PRNewswire/ -- QC Ware today announced that Q2B, the conference series dedicated to advancing the practical application of quantum technologies, is set to return to Tokyo for its second consecutive year. The event, co-hosted by QunaSys, will take place on July 19-20, 2023, at the prestigious Grand Hyatt in Tokyo.

Key Points: 
  • Q2B Tokyo serves as a vital platform for researchers, industry leaders, government representatives, and quantum computing vendors to connect, collaborate, and contribute to the growing quantum technologies (computing and sensing & timing) community in Asia.
  • This year's conference aims to further stimulate innovation and progress, fueling the growth of quantum computing across the region.
  • "Q2B Tokyo plays a vital role in fostering a robust quantum technologies community in Asia, providing a unique space for experts to share knowledge, inspire collaboration, and unlock the true potential of quantum technologies."
  • As a co-host for the event, QunaSys, a pioneer in quantum computing, brings its invaluable expertise and visionary approach to the conference.

Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, July 6, 2023
Associate Director of National Intelligence and Chief Information Officer, Clinical trial, Imp, Partnership, Pharmacy, Patient, Pharmaceutical industry

TORONTO, July 6, 2023 /PRNewswire-PRWeb/ -- An important webinar titled "Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions" is set to take place on July 20, 2023. The event will explore current clinical trial industry trends, clinical supply strategies and the resulting implications for patients.

Key Points: 
  • The featured speakers will discuss how to improve site and patient-centricity with the best clinical trial supply strategy.
  • TORONTO, July 6, 2023 /PRNewswire-PRWeb/ -- An important webinar titled "Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions" is set to take place on July 20, 2023.
  • The event will explore current clinical trial industry trends, clinical supply strategies and the resulting implications for patients.
  • The discussion, featuring Samit Bhatt, Vice President, Clinical Trial Patient Solutions at Myonex , Todd Luckritz, Associate Director, Clinical Trial Patient Solutions at Myonex, and Racheal Yoon, Associate Director, Clinical Trial Patient Solutions at Myonex, will delve into the various clinical trial supply options.

M-Files Recognized as a 2023 Gartner® Peer Insights™ Strong Performer for Content Services Platforms

Retrieved on: 
Monday, July 3, 2023
Consulting, Data Analytics, Professional Services, Cloud, Associate Director of National Intelligence and Chief Information Officer, Health care, Make It Happen, Keyword Services Platform, Information management, Better, Final good, Centaur, Biotechnology, ARR, Applied Data Research, Growth, Online shopping

M-Files, a global leader in information management, announced today that the company has been recognized by customers on Gartner Peer Insights™ as a Strong Performer in the June 2023 Gartner Peer Insights ‘Voice of the Customer’: Content Services Platforms report.

Key Points: 
  • M-Files, a global leader in information management, announced today that the company has been recognized by customers on Gartner Peer Insights™ as a Strong Performer in the June 2023 Gartner Peer Insights ‘Voice of the Customer’: Content Services Platforms report.
  • The company is recognized as a Strong Performer overall as well as the only vendor in this category for both the North America and Midsize Enterprise segments.
  • "Our Strong Performer recognition reflects our commitment to the M-Files guiding principles of "Make It Happen," "Help Others," and "Love Customers."
  • Gartner Peer Insights ‘Voice of the Customer’: Content Services Platforms report rates vendors based on the following categories – Product Capabilities, Sales Experience, Deployment Experience and Support Experience.

American Council of Learned Societies Names 2023 Luce/ACLS Collaborative Programming Grantees in Religion, Journalism, and International Affairs

Retrieved on: 
Tuesday, June 27, 2023
Associate Director of National Intelligence and Chief Information Officer, Social, Secularity, Education, Walter Cronkite School of Journalism and Mass Communication, American Council of Learned Societies, University, Theology, Public policy, Humanities, Learned society, American Council, Muslims, Associate, Organization, Student, Social justice, Aligarh Muslim University, ACLS, Islam, Identity, Religious studies, Arizona State University, Faculty, Knowledge, Time Inc., Management, Nursing, History, Journalism, Religion, Multicultural History Society of Ontario, Northeastern University

NEW YORK, June 27, 2023 /PRNewswire-PRWeb/ -- The American Council of Learned Societies (ACLS) is pleased to announce the recipients of the Luce/ACLS Collaborative Programming Grants in Religion, Journalism & International Affairs for 2023.

Key Points: 
  • NEW YORK, June 27, 2023 /PRNewswire-PRWeb/ -- The American Council of Learned Societies (ACLS) is pleased to announce the recipients of the Luce/ACLS Collaborative Programming Grants in Religion, Journalism & International Affairs for 2023.
  • Learn more about the Luce/ACLS Program in Religion, Journalism & International Affairs and additional ACLS programs for scholars in the humanities and interpretive social sciences.
  • Formed a century ago, the American Council of Learned Societies (ACLS) is a nonprofit federation of 80 scholarly organizations.
  • The Henry Luce Foundation seeks to enrich public discourse by promoting innovative scholarship, cultivating new leaders, and fostering international understanding.